Christer Allgulander
Biographic Data
| ID | 7181769 |
|---|---|
| NAME | Christer Allgulander |
| GIVEN NAMES | Christer |
| FAMILY NAME | Allgulander |
| SIGNATURE | ALLGULANDER C |
| AFFILIATIONS | Karolinska University Hospital |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 3 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1989 |
| LATEST PUBLICATION YEAR | 2011 |
| H-INDEX | 1 |
Cost of disorders of the brain in Europe 2010
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Regular hypnotic drug treatment in a sample of 32,679 Swedes
We studied Swedish survey responders who reported regular treatment with hypnotic drugs, to find associations to perceived health problems, inpatient psychiatric diagnoses, and subsequent suicide. Among 32,679 sampled Swedes, 26,952 (83%) participated, 500 of which (2%) reported regular hypnotic drug treatment. The rate of treatment was higher in women, and increased by age in both sexes. The major findings were high odds of concurrent psychoacti…
Psychiatric Diagnoses and Perceived Health Problems in a Sample of Working Swedes Treated with Psychoactive Medications
Findings of formal and subjective mental health problems among Swedish employees are presented as well as reviews of current Swedish policies on substance abuse and drug screening in the workplace. The focus is on the potential violation of medical confidentiality for employees with legitimate psychoactive drug medications and the lack of evidence linking the detection of various substances with impaired work performance. Data are drawn from a st…
Psychoactive drug use in a general population sample, Sweden
Three person-based computer files were linked to provide a data-set of a random sample of 32,679 Swedes, drawn for interviews regarding perceived health, socioeconomic conditions, and psychoactive drug use. All diagnoses from inpatient psychiatric care in the sample during a 15-year period and the causes of death after the sampling point were combined with the interview responses. Among those admitted for inpatient psychiatric care, substance abu…
Psychoactive drug use in a general population sample, Sweden
Three person-based computer files were linked to provide a data-set of a random sample of 32,679 Swedes, drawn for interviews regarding perceived health, socioeconomic conditions, and psychoactive drug use. All diagnoses from inpatient psychiatric care in the sample during a 15-year period and the causes of death after the sampling point were combined with the interview responses. Among those admitted for inpatient psychiatric care, substance abu…
Psychoactive drug use in a general population sample, Sweden
Three person-based computer files were linked to provide a data-set of a random sample of 32,679 Swedes, drawn for interviews regarding perceived health, socioeconomic conditions, and psychoactive drug use. All diagnoses from inpatient psychiatric care in the sample during a 15-year period and the causes of death after the sampling point were combined with the interview responses. Among those admitted for inpatient psychiatric care, substance abu…
Psychiatric Diagnoses and Perceived Health Problems in a Sample of Working Swedes Treated with Psychoactive Medications
Findings of formal and subjective mental health problems among Swedish employees are presented as well as reviews of current Swedish policies on substance abuse and drug screening in the workplace. The focus is on the potential violation of medical confidentiality for employees with legitimate psychoactive drug medications and the lack of evidence linking the detection of various substances with impaired work performance. Data are drawn from a st…
Regular hypnotic drug treatment in a sample of 32,679 Swedes
We studied Swedish survey responders who reported regular treatment with hypnotic drugs, to find associations to perceived health problems, inpatient psychiatric diagnoses, and subsequent suicide. Among 32,679 sampled Swedes, 26,952 (83%) participated, 500 of which (2%) reported regular hypnotic drug treatment. The rate of treatment was higher in women, and increased by age in both sexes. The major findings were high odds of concurrent psychoacti…
Cost of disorders of the brain in Europe 2010
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Medicine (5 works) · Mental health (4 works) · Psychiatry (4 works) · Environmental health (2 works) · Mental Health Treatment and Access (2 works) · Population (2 works) · Schizophrenia research and treatment (2 works) · Substance abuse (2 works) · Anxiety (1 work) · Burden of disease (1 work)